6Owens MWM,Markewitz BA,Payne DK.Outpatient management of chronic obstructive pulmonary disease.Am J Med Sci 1999;318:79-83.
7Worth H,Dhein Y.Does patient education modify behavior in the management of COPD? Patient Educ Couns 2004;52:267-70.
8Pauwels RA,Buist AS,Calverley PM,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease.NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GLOD)Workshop summary.Am J Respir Crit Care Med 2001; 163:1256-76.
9Celli BR,MacNee W,Agusti A,et al.Standards for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position patper.Eur Respir J 2004; 23:932-46.
10Bourbeau J,Julien M,Maltais F,et al.Reduction of hospital utilization in patients with chronic obstructive pulmonary disease:A disease-specific selfmanagement intervention.Arch Intern Med 2003; 163(5) :585-91.
6Baldi S, Aquilani R, Pinna GD, et al. Fat-free mass change after mutritional rehabilitation in weight losing COPD:role of insulin , C- reactive prutein and tissue hypoxia[J]. Int J Chron Obstruct Pulmon Dis,2010,18 (5) :29-39.
7Gupta B, Kant S, Mishra R, et al. Nutritional of chronic obstructive puhnonary disease patients admitted in hospita with acute exacedbation[J]. J ClinMedRes ,2010,2(2):68-74.
8Bakalar B, Duska F, Pachl J, et al. Parenterally administered dipep- tide alanyl-glutamine prevents worsening of insulin sensitivity in multi- pie-trauma patients[J]. Crit Care Med, 2006,34(2) :3814538.
9Farkas L, Stoelcked B, Jentsch N, et al. Muramyldipeptide modu- lates CXCL-8 release of BEAS-2B cells via NOD2 [J]. Stand J Immunol,2008,68 ( 3 ) : 315-322.
